← Leaderboards
Takeshi Iwata
Baylor College Of Medicine
$945,425
Attributed
$3,781,701
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2021–24$2M$1.5M$1M$500K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$3,781,701 · 1
By mechanism
U24$3,781,701 · 1
Top collaborators
- Yingbin Fu4 shared
- Michiko Mandai4 shared
- Tetsushi Sakuma2 shared
- Takashi Yamamoto2 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Rui Chen$25,188,663
- Graeme Mardon$16,816,134
- Ross Anthony Poche$9,387,509
- Milan Alexander Jamrich$7,502,046
- Alecia K Gross$4,339,614
Others in their field
Other Emerging Leaders on “Inherited”
- Leonard Freedman · Leidos Biomedical Research, Inc.$21,750,066
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Kim Doheny · Johns Hopkins University$10,776,613
- Colin Masters · University Of Melbourne$10,651,748
- Deborah Requesens · Coriell Institute For Medical Research$9,866,395
- Quy Phung · Leidos Biomedical Research, Inc.$8,400,509
Research focus
InheritedAblationHuman Embryonic Stem CellBiological ModelsCausal VariantCell PreparationAutosomeAcuteClinicDisease ProgressionEarly OnsetElectroretinographyEvaluationFunctional RestorationFundus ImagingCell Replacement TherapyCell TherapyGenerationsGenesGenetic ModelsGenome EditingHistologicHomologous GeneIn Vivo Imaging
Grant awards (4)
A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy$835,442
U24 · FY2024 · EY
A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy$960,512
U24 · FY2023 · EY
A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy$948,200
U24 · FY2022 · EY
A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy$1,037,547
U24 · FY2021 · EY